Vaccine Maker's Upsized Offering Leads Pair Of Biotech IPOs
Vaccine developer HilleVax Inc. rallied in debut trading Friday after it priced an upsized $200 million initial public offering, leading one of two biotechnology startups to go public and invigorate a...To view the full article, register now.
Already a subscriber? Click here to view full article